Editorial: Alzheimer's Disease Drug Development Pipeline 2020
J Prev Alzheimers Dis
.
2020;7(2):66-67.
doi: 10.14283/jpad.2020.12.
Author
M N Sabbagh
1
Affiliation
1
Marwan N. Sabbagh MD, FAAN, Cleveland Clinic Lou Ruvo Center for Brain Health, 888 W. Bonneville Ave, Las Vegas, NV 89106, sabbagm@ccf.org.
PMID:
32236392
PMCID:
PMC7437724
DOI:
10.14283/jpad.2020.12
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Alzheimer Disease / drug therapy*
Clinical Trials as Topic
Drug Development / trends*
Humans
Grants and funding
P20 AG068053/AG/NIA NIH HHS/United States
P20 GM109025/GM/NIGMS NIH HHS/United States
R01 AG059008/AG/NIA NIH HHS/United States